HANS PETER GULER Insider Trading $REGN REGENERON PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for HANS PETER GULER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of HANS PETER GULER. HANS PETER GULER is VP Clinical Programs in REGENERON PHARMACEUTICALS INC ($REGN) and VP, Clinical Sciences in REGENERON PHARMACEUTICALS INC ($REGN).
HANS PETER GULER in REGENERON PHARMACEUTICALS, INC.
Trading Symbol: REGNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of HANS PETER GULER: VP Clinical Programs, VP, Clinical Sciences
Holdings: 10,530 shares
Current Value: $3,766,476
Latest Transaction: Oct 12 2004
$REGN Market Capitalization: $37.03B
$REGN Previous Close: $357.69
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of HANS PETER GULER in REGENERON PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Option Exercise | M | 7.41 | 1,626 | 12,049 | 0 | |
Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Option Exercise | M | 7.44 | 500 | 3,719 | 0 | |
Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Option Exercise | M | 7.44 | 8,000 | 59,504 | 500 | |
Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Option Exercise | M | 7.44 | 3,500 | 26,033 | 8,500 | |
Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Option Exercise | M | 7.44 | 1,500 | 11,157 | 12,000 | |
Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Option Exercise | M | 7.44 | 1,500 | 11,157 | 13,500 | |
Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Option Exercise | M | 7.41 | 3,374 | 25,001 | 0 | |
Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Option Exercise | M | 7.41 | 3,500 | 25,935 | 3,374 | |
Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Option Exercise | M | 7.41 | 5,000 | 37,050 | 6,874 | |
Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Option Exercise | M | 7.41 | 2,500 | 18,525 | 11,874 | |
Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 7.91 | 1,626 | 12,862 | 10,530 | 12.2 K to 10.5 K (-13.38 %) |
Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Buy | M | 7.41 | 1,626 | 12,049 | 12,156 | 10.5 K to 12.2 K (+15.44 %) |
Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 7.91 | 3,374 | 26,688 | 10,530 | 13.9 K to 10.5 K (-24.27 %) |
Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Buy | M | 7.41 | 3,374 | 25,001 | 13,904 | 10.5 K to 13.9 K (+32.04 %) |
Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 7.93 | 3,500 | 27,752 | 10,530 | 14 K to 10.5 K (-24.95 %) |
Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Buy | M | 7.41 | 3,500 | 25,935 | 14,030 | 10.5 K to 14 K (+33.24 %) |
Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 7.93 | 5,000 | 39,650 | 10,530 | 15.5 K to 10.5 K (-32.20 %) |
Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Buy | M | 7.41 | 5,000 | 37,050 | 15,530 | 10.5 K to 15.5 K (+47.48 %) |
Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 7.94 | 2,500 | 19,855 | 10,530 | 13 K to 10.5 K (-19.19 %) |
Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Buy | M | 7.41 | 2,500 | 18,525 | 13,030 | 10.5 K to 13 K (+23.74 %) |
Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 7.94 | 500 | 3,971 | 10,530 | 11 K to 10.5 K (-4.53 %) |
Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Buy | M | 7.44 | 500 | 3,719 | 11,030 | 10.5 K to 11 K (+4.75 %) |
Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 7.95 | 8,000 | 63,600 | 10,530 | 18.5 K to 10.5 K (-43.17 %) |
Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Buy | M | 7.44 | 8,000 | 59,504 | 18,530 | 10.5 K to 18.5 K (+75.97 %) |
Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 7.96 | 3,500 | 27,846 | 10,530 | 14 K to 10.5 K (-24.95 %) |
Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Buy | M | 7.44 | 3,500 | 26,033 | 14,030 | 10.5 K to 14 K (+33.24 %) |
Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 7.96 | 1,500 | 11,943 | 10,530 | 12 K to 10.5 K (-12.47 %) |
Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Buy | M | 7.44 | 1,500 | 11,157 | 12,030 | 10.5 K to 12 K (+14.25 %) |
Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 8.10 | 1,500 | 12,146 | 10,530 | 12 K to 10.5 K (-12.47 %) |
Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Buy | M | 7.44 | 1,500 | 11,157 | 12,030 | 10.5 K to 12 K (+14.25 %) |
May 06 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Option Exercise | M | 7.44 | 20,000 | 148,760 | 15,000 | |
May 06 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 13.50 | 2,000 | 27,000 | 10,530 | 12.5 K to 10.5 K (-15.96 %) |
May 06 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 13.50 | 20,000 | 270,000 | 12,530 | 32.5 K to 12.5 K (-61.48 %) |
May 06 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Buy | M | 7.44 | 20,000 | 148,760 | 32,530 | 12.5 K to 32.5 K (+159.62 %) |
Dec 17 2003 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP, Clinical Scienc ... | Option Exercise | A | 13.00 | 15,000 | 195,000 | 15,000 | |
Dec 17 2003 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP, Clinical Scienc ... | Option Exercise | A | 13.00 | 5,000 | 65,000 | 5,000 | |
Dec 17 2003 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP, Clinical Scienc ... | Grant | A | 0.00 | 4,077 | 0 | 12,124 | 8 K to 12.1 K (+50.66 %) |
Page: 1